72 related articles for article (PubMed ID: 155828)
1. In vivo kinetics of blood cholinesterase inhibition by 9-amino-1, 2, 3, 4-tetrahydroacridine, its 7-methoxy derivative and physostigmine in rats.
Bajgar J; Fusek J; Patocka J; Hrdina V
Physiol Bohemoslov; 1979; 28(1):31-4. PubMed ID: 155828
[TBL] [Abstract][Full Text] [Related]
2. Changes of rat blood and tissue cholinesterases following administration of tacrine derivatives in vivo.
Bajgar J; Skopec F
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(1-2):73-81. PubMed ID: 8165433
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864
[TBL] [Abstract][Full Text] [Related]
4. Interaction of imipramine and 3-quinuclidyl benzilate with 9-amino-7-methoxy-1,2,3,4-tetrahydroacridine on the after-discharges in the limbic system.
Herink J; Fusek J; Bajgar J; Patocka J; Hrdina V
Act Nerv Super (Praha); 1978 Feb; 20(1):79-80. PubMed ID: 636789
[No Abstract] [Full Text] [Related]
5. Unexpected potentializing effect of a tacrine derivative (9-amino-7-methoxy-1,2,3,4 tetrahydroacridine) upon the non-epileptic myoclonus in baboons Papio papio.
Svejdová M; Rektor I; Silva-Barrat C; Menini C
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):961-6. PubMed ID: 2126145
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cholinesterase inhibitory activity of 6-, 7-methoxy-(and hydroxy-) tacrine derivatives.
Del Giudice MR; Borioni A; Mustazza C; Gatta F; Meneguz A; Volpe MT
Farmaco; 1996 Nov; 51(11):693-8. PubMed ID: 9035375
[TBL] [Abstract][Full Text] [Related]
7. An investigation of the effect of tacrine and physostigmine on spatial working memory deficits in the olfactory bulbectomised rat.
Hallam KT; Horgan JE; McGrath C; Norman TR
Behav Brain Res; 2004 Aug; 153(2):481-6. PubMed ID: 15265646
[TBL] [Abstract][Full Text] [Related]
8. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
Mesulam MM; Geula C; Morán MA
Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
[TBL] [Abstract][Full Text] [Related]
10. Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.
Thomsen T; Kewitz H; Pleul O
J Clin Chem Clin Biochem; 1988 Jul; 26(7):469-75. PubMed ID: 3065439
[TBL] [Abstract][Full Text] [Related]
11. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats.
Xiao WB; Nordberg A; Zhang X
J Pharmacol Exp Ther; 1993 May; 265(2):759-64. PubMed ID: 8496822
[TBL] [Abstract][Full Text] [Related]
12. [Biotransformation of the anticholinesterase agent, 9-amino-7-methoxy-1,2,3,4-tetrahydroacridine].
Patocka J; Bielavský J
Cesk Farm; 1991 May; 40(3):130-2. PubMed ID: 2070431
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine.
Thomsen T; Kaden B; Fischer JP; Bickel U; Barz H; Gusztony G; Cervos-Navarro J; Kewitz H
Eur J Clin Chem Clin Biochem; 1991 Aug; 29(8):487-92. PubMed ID: 1954303
[TBL] [Abstract][Full Text] [Related]
14. Physostigmine inhibition of 3',5'-cyclic AMP phosphodiesterase from cat sciatic nerve.
Curley WH; Standaert FG; Dretchen KL
J Pharmacol Exp Ther; 1984 Mar; 228(3):656-61. PubMed ID: 6323676
[TBL] [Abstract][Full Text] [Related]
15. [Effect of reversible inhibitors on the thermal denaturation of cholinesterases].
Tonkopiĭ VD; Padinker EB
Biull Eksp Biol Med; 1975 Apr; 79(4):51-2. PubMed ID: 1191768
[TBL] [Abstract][Full Text] [Related]
16. Comparison studies of tacrine and bis7-tacrine on the suppression of scopolamine-induced behavioral changes and inhibition of acetylcholinesterase in mice.
Pan SY; Yu ZL; Xiang CJ; Dong H; Fang HY; Ko KM
Pharmacology; 2009; 83(5):294-300. PubMed ID: 19365154
[TBL] [Abstract][Full Text] [Related]
17. Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABA(A) receptor antagonist.
Li CY; Wang H; Xue H; Carlier PR; Hui KM; Pang YP; Li ZW; Han YF
Neuroreport; 1999 Mar; 10(4):795-800. PubMed ID: 10208550
[TBL] [Abstract][Full Text] [Related]
18. In vitro inactivation of rat brain acetylcholinesterase by DSP-4 and its derivatives OS-21 and OS-23 and protective activity of tacrine (9-amino-1,2,3,4-tetrahydroacridine).
Patockal J; Jun D; Kucal K
Acta Medica (Hradec Kralove); 2005; 48(3-4):145-8. PubMed ID: 16640027
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Caricati-Neto A; D'angelo LC; Reuter H; Hyppolito Jurkiewicz N; Garcia AG; Jurkiewicz A
Eur J Pharmacol; 2004 Oct; 503(1-3):191-201. PubMed ID: 15496314
[TBL] [Abstract][Full Text] [Related]
20. [The amiridin and tacrine modulation of the cholinoreceptor activity and plasticity of snail neurons: the phenomenology and mechanisms].
Burov IuV; Drozdova EI; Pivovarov AS; Robakidze TN
Zh Vyssh Nerv Deiat Im I P Pavlova; 1993; 43(6):1202-9. PubMed ID: 8135063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
